The Anti-Trypanosome Drug Fexinidazole Shows Potential for Treating Visceral Leishmaniasis-Reference-Cited by-同舟云学术

The Anti-Trypanosome Drug Fexinidazole Shows Potential for Treating Visceral Leishmaniasis

Published:2012-02 Issue:119 Volume:4 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Wyllie Susan¹,Patterson Stephen¹,Stojanovski Laste¹,Simeons Frederick R. C.¹,Norval Suzanne¹,Kime Robert¹,Read Kevin D.¹,Fairlamb Alan H.¹

Affiliation:

1. Division of Biological Chemistry and Drug Discovery, Wellcome Trust Biocentre, College of Life Sciences, University of Dundee, Dundee DD1 5EH, Scotland, UK.

Abstract

Fexinidazole, a drug in clinical testing for African sleeping sickness, shows potential as an oral treatment for another neglected tropical disease.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference34 articles.

1. The Nobel Chronicles

2. Visceral leishmaniasis: elimination with existing interventions

3. World Health Organization Control of the Leishmaniases WHO Technical Report Series No. 949 (World Health Organization Geneva 2010).

4. Drug Resistance in Leishmaniasis

5. Developments in the treatment of visceral leishmaniasis

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigational new drugs for the treatment of leishmaniasis;Expert Opinion on Investigational Drugs;2024-09-10

2. Free Radical Production Induced by Nitroimidazole Compounds Lead to Cell Death in Leishmania infantum Amastigotes;Molecules;2024-08-26

3. Combination of the Topical Photodynamic Therapy of Chloroaluminum Phthalocyanine Liposomes with Fexinidazole Oral Self-Emulsifying System as a New Strategy for Cutaneous Leishmaniasis Treatment;Pharmaceutics;2024-04-07

4. Chemoselective Synthesis and Anti-Kinetoplastidal Properties of 2,6-Diaryl-4H-tetrahydro-thiopyran-4-one S-Oxides: Their Interplay in a Cascade of Redox Reactions from Diarylideneacetones;Molecules;2024-04-04

5. Phenotypic screening reveals a highly selective phthalimide-based compound with antileishmanial activity;PLOS Neglected Tropical Diseases;2024-03-25